Zobrazeno 1 - 10
of 356
pro vyhledávání: '"M. Edgerton"'
Autor:
Claire L. Ihle, Meredith D. Provera, Desiree M. Straign, E. Erin Smith, Susan M. Edgerton, Adrie Van Bokhoven, M. Scott Lucia, Philip Owens
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-9 (2019)
Abstract The most common metastatic lesions of prostate cancer are in bone and can be classified into three distinct pathology subtypes: lytic, blastic, and an indeterminate mixture of both. We investigated a cohort of decalcified formalin-fixed and
Externí odkaz:
https://doaj.org/article/608e11cfdb61466ebf25e7f5853008f7
Autor:
Harry Lee, Nipun Saini, Erin W. Howard, Amanda B. Parris, Zhikun Ma, Qingxia Zhao, Ming Zhao, Bolin Liu, Susan M. Edgerton, Ann D. Thor, Xiaohe Yang
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-14 (2018)
Abstract Although ErbB2-targeted therapeutics have significantly improved ErbB2+ breast cancer patient outcomes, therapeutic resistance remains a significant challenge. Therefore, the development of novel ErbB2-targeting strategies is necessary. Impo
Externí odkaz:
https://doaj.org/article/1473348218e04bcdaf8b1ef3f2493fea
Autor:
Paul S. MacLean, Steven M. Anderson, Pepper Schedin, Ann D. Thor, Susan M. Edgerton, Julie A. Houck, Reema S. Wahdan-Alaswad, Erin D. Giles, Elizabeth A. Wellberg, Michael C. Rudolph, L. Allyson Checkley
Representative electropherograms from ProteinSimple Wes{trade mark, serif} Western Blotting System for p-ACC, total ACC, p-AMPK, and Total AMPK.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::242610ad8bc0b468e9498e920e6b48ad
https://doi.org/10.1158/1940-6207.22533130.v1
https://doi.org/10.1158/1940-6207.22533130.v1
Autor:
Paul S. MacLean, Steven M. Anderson, Pepper Schedin, Ann D. Thor, Susan M. Edgerton, Julie A. Houck, Reema S. Wahdan-Alaswad, Erin D. Giles, Elizabeth A. Wellberg, Michael C. Rudolph, L. Allyson Checkley
Percent change in body weights of control and metformin-treated rats for study duration.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30c89bc81cf6347e749055b6142f78b2
https://doi.org/10.1158/1940-6207.22533136.v1
https://doi.org/10.1158/1940-6207.22533136.v1
Autor:
Paul S. MacLean, Steven M. Anderson, Pepper Schedin, Ann D. Thor, Susan M. Edgerton, Julie A. Houck, Reema S. Wahdan-Alaswad, Erin D. Giles, Elizabeth A. Wellberg, Michael C. Rudolph, L. Allyson Checkley
A) Percent CD68 positive cells in control versus metformin treated tumors (Con tumors, n=28; Met tumors, n=34) B) Percent CD68 positive cells in non-responding versus responding tumors (Regressed, n=17; Progressed, n=17).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a98f5ab40af8cfd3f6afffff52df409
https://doi.org/10.1158/1940-6207.22533133
https://doi.org/10.1158/1940-6207.22533133
Autor:
Paul S. MacLean, Steven M. Anderson, Pepper Schedin, Ann D. Thor, Susan M. Edgerton, Julie A. Houck, Reema S. Wahdan-Alaswad, Erin D. Giles, Elizabeth A. Wellberg, Michael C. Rudolph, L. Allyson Checkley
Fatty acid amounts (nmol/mg tumor) in responders versus non-responders. Significance denoted by p-value in right column.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a11f6dfe11ba28cbce1bf66318a58e8b
https://doi.org/10.1158/1940-6207.22533127.v1
https://doi.org/10.1158/1940-6207.22533127.v1
Autor:
Ann D. Thor, Bolin Liu, Bryan R. Haugen, Britta M. Jacobsen, Carol A. Sartorius, Elizabeth A. Wellberg, Jessica Finlay-Schultz, Aik Choon Tan, Hyun Min Kim, Hiba Salem, Susan M. Edgerton, Reema S. Wahdan-Alaswad
Purpose:Thyroid disease is a frequent comorbidity in women with breast cancer, and many require thyroid hormone replacement therapy (THRT). We postulated that THRT has a deleterious clinical effect mechanistically through hormonal interactions, nucle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05cf01cb31be2b3bc564080d3dba514f
https://doi.org/10.1158/1078-0432.c.6529971
https://doi.org/10.1158/1078-0432.c.6529971
Autor:
Ann D. Thor, Bolin Liu, Bryan R. Haugen, Britta M. Jacobsen, Carol A. Sartorius, Elizabeth A. Wellberg, Jessica Finlay-Schultz, Aik Choon Tan, Hyun Min Kim, Hiba Salem, Susan M. Edgerton, Reema S. Wahdan-Alaswad
Supplementary Tables S1, S2A, S2B, S2C, S3, S4, S5 and Supplementary Figures S1, S2, S3, S4, S5, S6, S7, and S8.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ad8d522d5353210a73ca25ba9374684
https://doi.org/10.1158/1078-0432.22478532.v1
https://doi.org/10.1158/1078-0432.22478532.v1
Autor:
Frank E. Jones, Rakesh Kumar, Kathleen C. Torkko, Susan M. Edgerton, Ann D. Thor, Anjali Naresh
Greater than 40% of breast cancer patients treated with tamoxifen exhibit de novo or acquired tumor resistance. Recent clinical evidence indicates that loss of expression of HER4 is an independent marker for tamoxifen resistance. In direct corroborat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a148ef3a84d2b6725add6987a05c4d9
https://doi.org/10.1158/0008-5472.c.6497466
https://doi.org/10.1158/0008-5472.c.6497466
Autor:
Frank E. Jones, Rakesh Kumar, Kathleen C. Torkko, Susan M. Edgerton, Ann D. Thor, Anjali Naresh
Supplementary Figure 1 from The HER4/4ICD Estrogen Receptor Coactivator and BH3-Only Protein Is an Effector of Tamoxifen-Induced Apoptosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b9ad272e11aae61c55e121b7739398a
https://doi.org/10.1158/0008-5472.22374486.v1
https://doi.org/10.1158/0008-5472.22374486.v1